Clicky

COMPASS Pathways Plc(CMPS) News

Date Title
May 13 COMPASS Pathways plc (NASDAQ:CMPS) Q1 2024 Earnings Call Transcript
May 9 Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
May 8 Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
May 8 Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
May 3 Compass Pathways to announce first quarter financial results on May 8, 2024
May 2 Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
Apr 29 Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
Apr 1 Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
Mar 31 20 Most Depressed Countries in Asia
Mar 28 Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
Mar 10 10 Alternatives to Antidepressant Medications
Mar 5 15 Highest Paying Jobs with a Psychology Degree
Mar 5 20 Countries with Most Antidepressant Users in the World
Mar 1 COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript
Feb 29 Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript
Feb 29 Compass Pathways PLC Reports Increased Annual Net Loss Amid Clinical Advancements
Feb 29 Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights
Feb 26 Compass Pathways to participate in upcoming TD Cowen investor conference
Feb 22 Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
Feb 19 Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.